指南与共识骨肌技术与安全CTMRPET

国际骨髓瘤工作组关于单克隆浆细胞疾病影像学检查的共识建议

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
指南 / 共识 · Lancet Oncol · 2019-01-01

国际骨髓瘤工作组针对多发性骨髓瘤治疗进展后对精准诊断的需求,制定单克隆浆细胞疾病不同疾病阶段影像学检查最优使用的共识建议。建议涵盖传统骨骼检查、低剂量全身CT、PET/CT和MRI等方法的适用场景,旨在标准化全球影像检查以利于结果比较和治疗统一。

要点

  • 低剂量全身CT检测骨病变的敏感度高于传统骨骼检查,可提供改变治疗与疾病管理的信息。
  • 骨与骨髓病变的检测对多发性骨髓瘤的检查至关重要,常决定是否开始治疗。
  • 微小残留病灶的检测对预后判断和治疗计划重要,凸显对精准评估治疗反应的敏感影像方法的需求。

核心结论

  • 国际骨髓瘤工作组决定建立指南,以规范单克隆浆细胞疾病在不同疾病阶段影像学方法的最优使用。
  • 这些临床试验内外的影像学建议将有助于全球范围内单克隆浆细胞疾病影像检查的标准化,从而使结果可比较并统一多发性骨髓瘤的治疗方法。

研究设计与样本

  • 国际骨髓瘤工作组(International Myeloma Working Group)发布的共识建议,针对单克隆浆细胞疾病影像学检查在不同疾病阶段的最优使用制定指南。
  • 共识涵盖的影像方法包括传统骨骼检查、低剂量全身CT、PET/CT和MRI。

临床应用与阅片要点

  • 骨与骨髓病变的检测在多发性骨髓瘤检查中至关重要,常决定是否开始治疗。
  • 低剂量全身CT检测骨病变的敏感度高于传统骨骼检查,可揭示改变治疗与疾病管理的信息,从而可能预防或延缓骨骼相关事件所致临床显著并发症和死亡的发生。
  • 微小残留病灶的检测对预后判断和治疗计划重要,凸显对精准评估治疗反应的敏感影像方法的需求。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the investigation of multiple myeloma and often dictates the decision to start treatment. Furthermore, detection of minimal residual disease is important for prognosis determination and treatment planning, and it has underscored an unmet need for sensitive imaging methods that accurately assess patient response to multiple myeloma treatment. Low-dose whole-body CT has increased sensitivity compared with conventional skeletal survey in the detection of bone disease, which can reveal information leading to changes in therapy and disease management that could prevent or delay the onset of clinically significant morbidity and mortality as a result of skeletal-related events. Given the multiple options available for the detection of bone and bone marrow lesions, ranging from conventional skeletal survey to whole-body CT, PET/CT, and MRI, the International Myeloma Working Group decided to establish guidelines on optimal use of imaging methods at different disease stages. These recommendations on imaging within and outside of clinical trials will help standardise imaging for monoclonal plasma cell disorders worldwide to allow the comparison of results and the unification of treatment approaches for multiple myeloma.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Hillengass J, Usmani S, Rajkumar SV, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019. PMID: 31162104. doi:10.1016/S1470-2045(19)30309-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。